Document Detail

Hospital-based medication reconciliation practices: a systematic review.
MedLine Citation:
PMID:  22733210     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Medication discrepancies at care transitions are common and lead to patient harm. Medication reconciliation is a strategy to reduce this risk.
OBJECTIVES: To summarize available evidence on medication reconciliation interventions in the hospital setting and to identify the most effective practices.
DATA SOURCES: MEDLINE (1966 through February 2012) and a manual search of article bibliographies.
STUDY SELECTION: Twenty-six controlled studies.
DATA EXTRACTION: Data were extracted on study design, setting, participants, inclusion/exclusion criteria, intervention components, timing, comparison group, outcome measures, and results.
DATA SYNTHESIS: Studies were grouped by type of medication reconciliation intervention-pharmacist related, information technology (IT), or other-and were assigned quality ratings using US Preventive Services Task Force criteria.
RESULTS: Fifteen of 26 studies reported pharmacist-related interventions, 6 evaluated IT interventions, and 5 studied other interventions. Six studies were classified as good quality. The comparison group for all the studies was usual care; no studies compared different types of interventions. Studies consistently demonstrated a reduction in medication discrepancies (17 of 17 studies), potential adverse drug events (5 of 6 studies), and adverse drug events (2 of 2 studies) but showed an inconsistent reduction in postdischarge health care utilization (improvement in 2 of 8 studies). Key aspects of successful interventions included intensive pharmacy staff involvement and targeting the intervention to a high-risk patient population.
CONCLUSIONS: Rigorously designed studies comparing different inpatient medication reconciliation practices and their effects on clinical outcomes are scarce. Available evidence supports medication reconciliation interventions that heavily use pharmacy staff and focus on patients at high risk for adverse events. Higher-quality studies are needed to determine the most effective approaches to inpatient medication reconciliation.
Stephanie K Mueller; Kelly Cunningham Sponsler; Sunil Kripalani; Jeffrey L Schnipper
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Archives of internal medicine     Volume:  172     ISSN:  1538-3679     ISO Abbreviation:  Arch. Intern. Med.     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-24     Completed Date:  2012-10-11     Revised Date:  2013-07-25    
Medline Journal Info:
Nlm Unique ID:  0372440     Medline TA:  Arch Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1057-69     Citation Subset:  AIM; IM    
Brigham and Women's Hospital Hospitalist Service and Division of General Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Toxicity / prevention & control
Medication Reconciliation*
Grant Support
1 R18 HS019598-01/HS/AHRQ HHS; R01 HL089755/HL/NHLBI NIH HHS; R01 HL089755/HL/NHLBI NIH HHS; T32-HP10251//PHS HHS
Comment In:
Arch Intern Med. 2012 Jul 23;172(14):1069-70   [PMID:  22733283 ]
JAMA Intern Med. 2013 Feb 11;173(3):246-7   [PMID:  23400661 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A simplified protocol for genetic transformation of switchgrass (Panicum virgatum L.).
Next Document:  Insights into cell membrane microdomain organization from live cell single particle tracking of the ...